8 patents
Utility
Antibodies to Misfolded Amyloid Beta
11 May 23
The disclosure pertains to antibodies that bind A-beta oligomers and methods of using said antibodies.
Neil R. Cashman, Johanne Kaplan, Ebrima Gibbs
Filed: 31 Mar 21
Utility
Conformation-specific Epitopes In Alpha-synuclein, Antibodies Thereto and Methods Related Thereof
16 Feb 23
The disclosure pertains to conformational epitopes in alpha-synuclein, antibodies thereto and methods of making and using immunogens and antibodies specific thereto.
Neil R. CASHMAN, Steven S. PLOTKIN, Xubiao PENG, Johanne KAPLAN
Filed: 7 Oct 19
Utility
Conformation-specific Epitopes In Tau, Antibodies Thereto and Methods Related Thereof
14 Jul 22
The disclosure pertains to conformational epitopes in oligomeric tau, antibodies thereto and methods of making and using immunogens and antibodies specific thereto.
Steven S. Plotkin, Neil R. Cashman, Johanne Kaplan
Filed: 27 May 20
Utility
Antibodies to Misfolded TDP-43 and Methods of Use
24 Feb 22
The disclosure pertains to antibodies that specifically bind W68 in the context of DAGWGNL (SEQ ID NO: 1).
Neil R. Cashman, Johanne Kaplan
Filed: 16 Dec 19
Utility
Methods and compositions for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
11 Feb 21
The disclosure pertains to methods of treating or preventing a disease or condition associated with and/or induced by soluble A-beta oligomer such as Alzheimer's disease by administering to a subject in need thereof conformation specific and/or selective antibodies or binding fragments thereof and related products.
Neil R. CASHMAN, Steven S. PLOTKIN, Judith Maxwell SILVERMAN, Ebrima GIBBS, Johanne KAPLAN
Filed: 21 Aug 20
Utility
Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
24 Aug 20
The disclosure pertains to methods of treating or preventing a disease or condition associated with and/or induced by soluble A-beta oligomer such as Alzheimer's disease by administering to a subject in need thereof conformation specific and/or selective antibodies or binding fragments thereof and related products.
Neil R. Cashman
Filed: 30 Sep 18
Utility
Antibodies to Amyloid Beta
10 Jun 20
The disclosure pertains to antibodies that bind A-beta oligomers and methods of making and using said antibodies.
Neil R. Cashman, Steven S. Plotkin, Johanne Kaplan, Judith Maxwell Silverman, Ebrima Gibbs
Filed: 17 Jul 18
Utility
Antibodies to Amyloid Beta
3 Jun 20
The disclosure pertains to antibodies that bind A-beta oligomers and methods of making and using said antibodies.
Neil R. Cashman, Steven S. Plotkin, Judith Maxwell Silverman, Ebrima Gibbs, Johanne Kaplan
Filed: 17 Jul 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first